In the latest trading session, 36.71 million Adial Pharmaceuticals Inc (NASDAQ:ADIL) shares changed hands as the company’s beta touched 1.13. With the company’s most recent per share price at $0.86 changing hands around $0.1 or 13.05% at last look, the market valuation stands at $5.60M. ADIL’s current price is a discount, trading about -384.88% off its 52-week high of $4.17. The share price had its 52-week low at $0.72, which suggests the last value was 16.28% up since then.

Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information

Instantly ADIL is in green as seen in intraday trades today. With action 9.44%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -14.38%, with the 5-day performance at 9.44% in the green. However, in the 30-day time frame, Adial Pharmaceuticals Inc (NASDAQ:ADIL) is -11.58% down.

Adial Pharmaceuticals Inc (ADIL) estimates and forecasts

According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 38.36%. The 2025 estimates are for Adial Pharmaceuticals Inc earnings to increase by 28.06%, but the outlook for the next 5-year period is at 32.14% per year.

Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 34.63 shares estimated at $31139.0 under it, the former controlled 0.54% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.15% of the shares, roughly 9.36 shares worth around $8415.0.